Can PCOS Be Misdiagnosed? Two Errors, Different Harms

Can PCOS actually be misdiagnosed?

Yes, in two directions that carry different consequences, and the 2023 international evidence-based guideline’s own diagnostic algorithm treats the exclusion step as part of making the diagnosis, not an optional add-on. Its published flowchart requires TSH, prolactin, 17-hydroxyprogesterone and FSH before PCOS is confirmed, with Cushing’s syndrome and adrenal or ovarian tumours tested for when clinically indicated, and hypogonadotrophic hypogonadism — the technical name for a periods-stopping energy deficit — ruled out with LH and FSH. Skip that step in either direction and you get a different error: over-diagnosis hands someone a label, and sometimes a treatment plan, for a condition they do not have; under-diagnosis leaves a real case unconfirmed, sometimes for years. This page covers both, and treats them as different problems because they are — a missed over-diagnosis can make a person’s actual condition worse, while under-diagnosis mostly costs time.

One naming note, mentioned once: in May 2026 PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Nothing about which conditions get confused with it, or how they’re excluded, changed with the name. This article uses PCOS because that’s still what most readers search.

What six conditions get mistaken for PCOS, and how does each one actually get ruled out?

Each of the six look-alikes below produces some version of irregular cycles, excess hair, or acne — the same surface picture as PCOS — through a completely different mechanism, and each has a specific test that tells it apart.

The full comparison between non-classic CAH and PCOS, including the exact 17-hydroxyprogesterone cutoffs, and the full comparison with Cushing’s syndrome both go deeper than the summary above. High prolactin against PCOS covers the specific prolactin level and the pitfall that most often confuses the two. The one condition in that table with no dedicated page of its own — because it deserves one, and hasn’t had it — is the last row.

Why does functional hypothalamic amenorrhea deserve more than a line in the table?

Because it’s the one look-alike where the standard PCOS advice actively makes things worse, and that makes it the most consequential misdiagnosis on this list. FHA is a stress- or energy-deficit-driven shutdown of the reproductive hormone axis — the 2017 Endocrine Society clinical practice guideline defines it as amenorrhea from suppressed hypothalamic GnRH pulsing, most often driven by some combination of low energy availability, weight loss, high exercise volume, and psychological stress, whether or not any one factor looks extreme on its own. The hormone pattern runs in the opposite direction from PCOS: LH and FSH sit low or low-normal instead of the higher LH-to-FSH ratio often seen in PCOS, oestradiol is low rather than the sustained oestrogen exposure typical of PCOS-related anovulation, and androgens are not elevated.

The harm is specific and mechanical, not just a labelling problem. PCOS management commonly includes advice to reduce calorie intake and increase exercise, because insulin resistance and excess energy intake are genuinely part of PCOS’s metabolic picture for some phenotypes. FHA is caused by the opposite problem — an energy deficit the body cannot sustain alongside normal reproductive function — so identical advice given to someone with FHA instead of PCOS deepens the exact deficit driving the amenorrhea in the first place. The 2017 guideline’s recommended approach runs the other way: identifying and correcting the energy deficit, typically through a multidisciplinary team addressing nutrition, training load and psychological stress together, rather than a further push toward “eat less, move more.”

Why is diagnosing PCOS from an ultrasound alone in a teenager a specific, named mistake?

Because the guideline says explicitly that there is no reliable way to read a scan that way at that age: “there are no definitive criteria to define polycystic ovary morphology on ultrasound in adolescents; hence, it is not recommended” at all, full stop, not narrowed to a subset of scans. Multi-follicular ovaries are a normal feature of a still-maturing hormonal axis in the years just after a first period, so a scan reading built for adults flags a large share of healthy teenagers as abnormal. The guideline’s practical marker for “still young enough that this applies” is eight years post-menarche: those with PCOS features who don’t yet meet full criteria are re-assessed at or before that point, not diagnosed on a scan finding in the meantime.

The same guideline update makes a related point for adults, worth naming because it shows the concern about over-diagnosis is coming from the guideline itself, not just from this article: adding anti-Müllerian hormone as an alternative to ultrasound was done, in the guideline’s own words, “without evidence of overdiagnosis” from that specific change — and a separate recommendation says AMH and ultrasound should not both be run together, specifically “to limit over-diagnosis.” The adult version of the same mistake — a single scan finding treated as a full diagnosis instead of one leg of three — is covered in full separately. The complete set of adolescent-specific rules for PCOS covers what’s used instead of ultrasound, and how cycle irregularity is judged differently before age 20.

What does under-diagnosis look like, and why does it take so long to correct?

More than a third of women in one large survey — 33.6% of 1,385 respondents — reported waiting over two years for a PCOS diagnosis, and 47.1% saw three or more health professionals first, according to a 2017 study of PCOS diagnosis experiences. That’s self-selected data from women recruited through support-group websites, not a population-representative figure, but it matches what almost every other survey on the topic finds. Under-diagnosis clusters around presentations that don’t match the picture most people — clinicians included — associate with PCOS: a lean body size, where insulin resistance still gets tested for less often even though it’s present in a meaningful share of lean-phenotype cases; regular cycles, where androgen excess plus polycystic ovaries alone (phenotype C) gets missed because “PCOS” is read as synonymous with irregular periods; and referral-setting bias, where a systematic review comparing referral to unselected populations found milder presentations are under-represented in the clinic populations most diagnostic assumptions are built from. The full diagnostic work-up, broken down phenotype by phenotype shows exactly which two of three criteria your presentation could satisfy.

This won’t settle your own diagnosis, and it isn’t meant to

Reading this article cannot tell you which of these six conditions, if any, applies to you — that requires your actual LH, FSH, oestradiol, TSH, prolactin and 17-hydroxyprogesterone results, read together with your cycle and symptom history by a clinician. It also will not help if your androgens are markedly elevated and rose quickly: that pattern needs prompt, direct evaluation for a tumour, not a checklist read at home. And it does not mean every PCOS diagnosis you’ve been given deserves a second look — most people who meet two of the three Rotterdam criteria, with the standard exclusion panel run, do in fact have PCOS. This page is for the specific, documented gap between what a full work-up requires and what sometimes actually happens in a rushed visit.